Glucose Restriction Triggers Neurodegeneration in Mitochondrial DNA-Depleted Neurons
New research warns that caloric restriction strategies may backfire in patients with mitochondrial DNA depletion, accelerating neurodegeneration via calcium overload.
Summary
Researchers discovered that glucose restriction — typically beneficial for epilepsy — can paradoxically cause neurodegeneration in neurons lacking mitochondrial DNA (mtDNA). Using a mouse model where the HSV-1 protein UL12.5 depleted brain mtDNA, they observed epileptic activity and heightened neural excitability. When these mtDNA-depleted neurons were subjected to glucose restriction, mitochondria-ER contacts increased, triggering dangerous calcium overload in mitochondria. Fasting worsened motor dysfunction and accelerated neurodegeneration in affected mice. Critically, blocking the IP3R calcium channel with 2-APB prevented this degeneration, identifying a potential therapeutic target. The findings suggest glucose restriction may be contraindicated in patients with mtDNA depletion disorders.
Detailed Summary
Mitochondrial DNA (mtDNA) mutations and depletion are known contributors to epilepsy and neurodegenerative disease, yet their precise mechanisms have remained incompletely understood. This study addresses that gap by establishing the first animal and neuronal models specifically designed to study mitochondrial epilepsy.
The research team used the Herpes Simplex Virus Type 1 protein UL12.5 to deplete mtDNA in mouse brain tissue, generating an epileptic phenotype with abnormal EEG patterns and increased hippocampal neural excitability. In parallel, mtDNA-depleted neurons cultured in vitro (rho- neurons) also exhibited epilepsy-like abnormal electrical activity, validating the model across systems.
A central and surprising finding emerged when glucose restriction (GR) — a strategy commonly used to reduce seizure activity — was applied to these rho- neurons. Rather than providing neuroprotection, GR induced neurodegeneration. Mechanistically, mtDNA depletion caused increased physical contacts between mitochondria and the endoplasmic reticulum (ER), which in turn facilitated excessive calcium transfer into mitochondria under glucose-restricted conditions. Notably, mitochondrial membrane potential and motility remained unchanged, isolating calcium dysregulation as the key pathological driver.
In vivo, fasting-induced glucose restriction caused early motor dysfunction, accelerated epilepsy progression, and worsened neurodegeneration in UL12.5 mice. Strikingly, treatment with the IP3R inhibitor 2-APB blocked the fasting-induced neurodegeneration, pointing to the ER-to-mitochondria calcium transfer pathway as a druggable target.
These findings carry significant clinical implications. Caloric and glucose restriction are increasingly explored as interventions for epilepsy and neurological conditions, but this study suggests they may be harmful — potentially dangerous — in patients harboring mtDNA depletion. Caution and genetic screening may be warranted before applying dietary restriction protocols in mitochondrial disease populations.
Key Findings
- mtDNA depletion via HSV-1 UL12.5 protein induces epileptic EEG patterns and increased hippocampal excitability in mice.
- Glucose restriction causes neurodegeneration in mtDNA-depleted neurons by triggering mitochondrial calcium overload.
- Increased mitochondria-ER contact sites drive excessive calcium transfer under glucose restriction in rho- neurons.
- The IP3R inhibitor 2-APB blocks fasting-induced neurodegeneration, identifying a potential therapeutic target.
- Fasting accelerates epilepsy progression and motor dysfunction in mtDNA-depleted mice, contradicting expected benefits.
Methodology
Researchers created a mouse model using the HSV-1 UL12.5 protein to deplete brain mtDNA and complemented this with in vitro rho- neuron cultures. EEG recordings, calcium imaging, and mitochondrial functional assays were used to characterize disease mechanisms. The IP3R inhibitor 2-APB was employed to test the causal role of ER-mitochondria calcium transfer in neurodegeneration.
Study Limitations
The study relies on a viral protein (UL12.5) to model mtDNA depletion, which may not fully replicate genetic mitochondrial diseases seen in humans. Findings are primarily in mouse and in vitro models, and clinical translation requires further validation in human patient cohorts. The full abstract does not detail whether 2-APB was tested in vivo or only in cell culture models.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.